Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 9:09AM AEST - The Australian Stockmarket opens in 51 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
Targacept, Inc. (TRGT)
8:00AM AEST:
20.51 USD
0.20 (0.98%)
MORE ON TRGT
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Targacept, Inc.
(NGM:TRGT) Delayed quote data
Last Trade:
20.51 USD
Trade Time:
8:00AM AEST
Change:
0.20 (0.98%)
Prev Close:
20.31
Open:
20.41
Bid:
19.86
x 100
Ask:
21.50
x 100
1y Target Est:
28.50
Day's Range:
20.38 - 20.86
52wk Range:
2.00 - 24.50
Volume:
143,250
Avg Vol
(3m)
:
244,623
Market Cap:
568.13M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.74
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
Add TRGT to Portfolio
Download Data
HEADLINES
Targacept Awarded a Grant from The Michael J. Fox Foundation to Conduct Biomarker Research for Parkinson's Disease
Business Wire
(Tue 12:55AM)
Targacept to Report Fourth Quarter and 2009 Financial Results on February 11, 2010
Business Wire
(Fri, Feb 5)
Targacept to Present at BIO CEO & Investor Conference
Business Wire
(Wed, Feb 3)
1-Star Stocks Poised to Plunge: Cytori Therapeutics?
at Motley Fool
(Sat, Jan 30)
TARGACEPT INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
(Tue, Jan 26)
Targacept execs to speak at Bio event
at bizjournals.com
(Thu, Jan 21)
1-Star Stocks Poised to Plunge: Dollar Thrifty?
at Motley Fool
(Wed, Jan 20)
Targacept gets $200M payment from AstraZeneca
AP
(Tue, Jan 12)
Will the Bull Trend End & 3 Power Ratings Stocks
TradingMarkets.com
(Tue, Jan 12)
Targacept banks $200M payment
at bizjournals.com
(Tue, Jan 12)
More Headlines for TRGT...
ANALYST
EPS Est (next year)
(Dec-09)
:
-0.87
EPS Est (in 2 years)
(Dec-10)
:
0.80
Avg Rec (current)*:
1.6
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Targacept, Inc., a biopharmaceutical company, engages in the design, discovery, and development of neuronal nicotinic receptor (NNR) Therapeutics for the treatment of diseases and disorders of the central nervous system.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices